• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 MGIT 960 系统快速诊断结核病和耐多药。

Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system.

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Ann Lab Med. 2012 Jul;32(4):264-9. doi: 10.3343/alm.2012.32.4.264. Epub 2012 Jun 20.

DOI:10.3343/alm.2012.32.4.264
PMID:22779067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3384807/
Abstract

BACKGROUND

The purpose of this study was to compare the turnaround time for liquid culturing and primary anti-tuberculous drug susceptibility testing (DST) performed using the mycobacteria growth indicator tube (MGIT) 960 system (Becton Dickinson, USA) with that for conventional culturing and DST (by the absolute concentration method) performed using solid culture medium and to determine the concordance rates of DST results obtained using these 2 methods.

METHODS

In this retrospective study, we compared the turnaround times from receiving the request for mycobacterial culture to reporting the DST results before and after the introduction of the MGIT 960 system. Further, we determined the concordance between DST results for isoniazid and rifampin for Mycobacterium tuberculosis isolates obtained using the MGIT 960 system and the absolute concentration method, which was conducted at the Korean Institute of Tuberculosis.

RESULTS

The overall turnaround time for mycobacterial culturing and DST was 27 days for liquid culturing and DST using the MGIT 960 system versus approximately 70 days for culturing on solid medium and DST with the absolute concentration method (P<0.001). There was a good concordance between findings of DST obtained with the 2 methods (97.2%, kappa coefficient=0.855 for rifampin; and 95.6%, kappa coefficient=0.864 for isoniazid), for 1,083 clinical isolates.

CONCLUSIONS

The automated MGIT 960 system for culturing and DST of M. tuberculosis was successfully introduced in a hospital laboratory setting in Korea with significant shortening of the turnaround time.

摘要

背景

本研究旨在比较使用分枝杆菌生长指示管(MGIT)960 系统(美国 Becton Dickinson)进行液体培养和初步抗结核药物敏感性试验(DST)与使用固体培养基进行常规培养和 DST(绝对浓度法)的周转时间,并确定这两种方法获得的 DST 结果的一致性率。

方法

在这项回顾性研究中,我们比较了引入 MGIT 960 系统前后从收到分枝杆菌培养请求到报告 DST 结果的周转时间。此外,我们还确定了在韩国结核研究所使用 MGIT 960 系统和绝对浓度法获得的结核分枝杆菌分离株异烟肼和利福平的 DST 结果之间的一致性。

结果

液体培养和 MGIT 960 系统 DST 的分枝杆菌培养和 DST 的总周转时间为 27 天,而固体培养基培养和绝对浓度法 DST 约为 70 天(P<0.001)。两种方法的 DST 结果之间存在良好的一致性(利福平的一致性为 97.2%,kappa 系数=0.855;异烟肼的一致性为 95.6%,kappa 系数=0.864),共 1083 例临床分离株。

结论

在韩国的一家医院实验室环境中,成功引入了用于培养和检测结核分枝杆菌的自动化 MGIT 960 系统,显著缩短了周转时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/3384807/a3c20ca4e3d2/alm-32-264-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/3384807/a3c20ca4e3d2/alm-32-264-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb33/3384807/a3c20ca4e3d2/alm-32-264-g001.jpg

相似文献

1
Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system.使用 MGIT 960 系统快速诊断结核病和耐多药。
Ann Lab Med. 2012 Jul;32(4):264-9. doi: 10.3343/alm.2012.32.4.264. Epub 2012 Jun 20.
2
Advantages of the AdvanSure MDR-TB GenoBlot assay containing disputed rpoB mutation-specific probes in a routine clinical laboratory setting.AdvanSure MDR-TB GenoBlot assay 含有有争议的 rpoB 突变特异性探针,在常规临床实验室环境中的优势。
Respir Med. 2019 Jan;146:71-75. doi: 10.1016/j.rmed.2018.12.001. Epub 2018 Dec 12.
3
Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.用于结核分枝杆菌对异烟肼和利福平药敏试验的分枝杆菌生长指示管
Diagn Microbiol Infect Dis. 1997 Jul;28(3):153-6. doi: 10.1016/s0732-8893(97)00006-0.
4
Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.评价微观观察药物敏感性检测在越南诊断耐多药结核病中的应用。
BMC Infect Dis. 2012 Mar 1;12:49. doi: 10.1186/1471-2334-12-49.
5
Evaluation of mycobacteria growth indicator tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital.在西伯利亚一所监狱医院中,评估用于呼吸道标本中结核分枝杆菌直接和间接药敏试验的分枝杆菌生长指示管。
J Clin Microbiol. 2001 Apr;39(4):1501-5. doi: 10.1128/JCM.39.4.1501-1505.2001.
6
Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.用于结核分枝杆菌对异烟肼和利福平药敏试验的分枝杆菌生长指示管的评估
Diagn Microbiol Infect Dis. 1995 Aug;22(4):325-9. doi: 10.1016/0732-8893(95)00147-7.
7
Direct Susceptibility Testing on MGIT 960 TB System: A Rapid Method for Detection of Drug Resistant Tuberculosis.在MGIT 960结核系统上进行直接药敏试验:一种检测耐药结核病的快速方法。
J Coll Physicians Surg Pak. 2018 Aug;28(8):590-593. doi: 10.29271/jcpsp.2018.08.590.
8
Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.结核分枝杆菌复合群对标准短程化疗中使用的四种一线抗结核药物的快速、自动化、非放射性药敏试验。
Diagn Microbiol Infect Dis. 2004 Oct;50(2):103-7. doi: 10.1016/j.diagmicrobio.2004.04.001.
9
Modified protocol for drug susceptibility testing of MGIT cultures of Mycobacterium tuberculosis by the MGIT 960.采用MGIT 960对结核分枝杆菌MGIT培养物进行药敏试验的改良方案。
Diagn Microbiol Infect Dis. 2017 Feb;87(2):108-111. doi: 10.1016/j.diagmicrobio.2016.10.023. Epub 2016 Oct 30.
10
Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study.使用 Bactec MGIT 960 系统快速检测结核分枝杆菌直接药敏试验:一项多中心研究。
J Clin Microbiol. 2012 Feb;50(2):435-40. doi: 10.1128/JCM.05188-11. Epub 2011 Dec 7.

引用本文的文献

1
CRISPR-Cas9-based electrochemical biosensor for the detection of gene mutations in isoniazid-resistant tuberculosis.基于CRISPR-Cas9的电化学生物传感器用于检测耐异烟肼结核病中的基因突变
ADMET DMPK. 2025 Jun 17;13(3):2766. doi: 10.5599/admet.2766. eCollection 2025.
2
Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysis.耐多药结核病患者合并与不合并糖尿病的耐药情况比较分析。
BMC Infect Dis. 2024 Aug 9;24(1):807. doi: 10.1186/s12879-024-09712-3.
3
High-throughput nanopore targeted sequencing for efficient drug resistance assay of .

本文引用的文献

1
New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis.新型且改良的耐药性肺结核诊断技术。
Curr Opin Pulm Med. 2011 May;17(3):134-41. doi: 10.1097/MCP.0b013e3283452346.
2
Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector.公立结核病医院耐多药结核病患者的治疗结果和死亡率。
J Korean Med Sci. 2011 Jan;26(1):33-41. doi: 10.3346/jkms.2011.26.1.33. Epub 2010 Dec 22.
3
Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection.
用于高效耐药性检测的高通量纳米孔靶向测序
Front Microbiol. 2024 May 22;15:1331656. doi: 10.3389/fmicb.2024.1331656. eCollection 2024.
4
Disease spectrum and prognostic factors in patients treated for tuberculous meningitis in Shaanxi province, China.中国陕西省结核性脑膜炎患者的疾病谱及预后因素
Front Microbiol. 2024 May 17;15:1374458. doi: 10.3389/fmicb.2024.1374458. eCollection 2024.
5
Clinical Course of Patients With Mediastinal Lymph Node Tuberculosis and Risk Factors for Paradoxical Responses.纵隔淋巴结结核患者的临床病程和反常反应的危险因素。
J Korean Med Sci. 2023 Dec 4;38(47):e348. doi: 10.3346/jkms.2023.38.e348.
6
Near-field sensor array with 65-GHz CMOS oscillators can rapidly and comprehensively evaluate drug susceptibility of Mycobacterium.具有 65GHz CMOS 振荡器的近场传感器阵列可快速全面地评估分枝杆菌的药物敏感性。
Sci Rep. 2023 Mar 7;13(1):3825. doi: 10.1038/s41598-023-30873-9.
7
Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration.BACTEC MGIT 960 系统对利福平药物敏感性测试在当前世卫组织临界浓度下结核分枝杆菌的性能评估。
J Clin Microbiol. 2023 Jan 26;61(1):e0108622. doi: 10.1128/jcm.01086-22. Epub 2023 Jan 5.
8
A Rapid Assessing Method of Drug Susceptibility Using Flow Cytometry for Mycobacterium tuberculosis Isolates Resistant to Isoniazid, Rifampin, and Ethambutol.一种使用流式细胞术对耐异烟肼、利福平及乙胺丁醇的结核分枝杆菌分离株进行药敏快速评估的方法
Tuberc Respir Dis (Seoul). 2022 Jul;85(3):264-272. doi: 10.4046/trd.2021.0134. Epub 2022 Feb 23.
9
Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China.中国深圳的利奈唑胺治疗方案使利福平/耐多药结核性脑膜炎的死亡率降低。
BMC Infect Dis. 2021 Sep 28;21(1):1015. doi: 10.1186/s12879-021-06705-4.
10
Diagnosis and treatment of multidrug-resistant tuberculosis.耐多药结核病的诊断与治疗
Yeungnam Univ J Med. 2020 Oct;37(4):277-285. doi: 10.12701/yujm.2020.00626. Epub 2020 Sep 4.
耐药结核病的诊断:检测的可靠性和速度。
Int J Tuberc Lung Dis. 2010 Feb;14(2):131-40.
4
Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results.利福平药物敏感性试验结果高度不一致的结核分枝杆菌菌株。
J Clin Microbiol. 2009 Nov;47(11):3501-6. doi: 10.1128/JCM.01209-09. Epub 2009 Sep 16.
5
Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis.耐多药结核病的治疗结局:系统评价和荟萃分析。
PLoS One. 2009 Sep 9;4(9):e6914. doi: 10.1371/journal.pone.0006914.
6
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.2002 - 2007年抗结核药物耐药性流行病学:全球抗结核药物耐药性监测项目的最新分析
Lancet. 2009 May 30;373(9678):1861-73. doi: 10.1016/S0140-6736(09)60331-7. Epub 2009 Apr 15.
7
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.耐多药结核病患者的治疗结果:系统评价与荟萃分析。
Lancet Infect Dis. 2009 Mar;9(3):153-61. doi: 10.1016/S1473-3099(09)70041-6.
8
[Evaluation of combination of BACTEC mycobacteria growth indicator tube 960 system and Ogawa media for mycobacterial culture].[BACTEC 960 分枝杆菌生长指示管系统与小川培养基联合用于分枝杆菌培养的评估]
Korean J Lab Med. 2008 Aug;28(4):299-306. doi: 10.3343/kjlm.2008.28.4.299.
9
Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis.广泛耐药结核病患者的治疗结果与长期生存情况
Am J Respir Crit Care Med. 2008 Nov 15;178(10):1075-82. doi: 10.1164/rccm.200801-132OC. Epub 2008 Aug 14.
10
Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.未感染艾滋病毒的耐多药和广泛耐药结核病患者的治疗结果。
Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.